Opioid growth factor and the treatment of human pancreatic cancer: A review

Por Zagon, Ian S, McLaughlin, Patricia J
Publicado em 2014

Intermittent blockade of OGFr and treatment of autoimmune disorders

Por Zagon, Ian S, McLaughlin, Patricia J
Publicado no Exp Biol Med (Maywood) (2018)

Topical Naltrexone as Treatment for Type 2 Diabetic Cutaneous Wounds

Por Immonen, Jessica A., Zagon, Ian S., McLaughlin, Patricia J.
Publicado em 2014

Featured Article: Nuclear export of opioid growth factor receptor is CRM1 dependent

Por Kren, Nancy P, Zagon, Ian S, McLaughlin, Patricia J
Publicado no Exp Biol Med (Maywood) (2015)

The Yin and Yang of the Opioid Growth Regulatory System: Focus on Diabetes—The Lorenz E. Zimmerman Tribute Lecture

Por Sassani, Joseph W., Mc Laughlin, Patricia J., Zagon, Ian S.
Publicado no J Diabetes Res (2016)

Featured Article: Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone

Por Ludwig, Michael D, Zagon, Ian S, McLaughlin, Patricia J
Publicado no Exp Biol Med (Maywood) (2017)

Featured Article: Modulation of the OGF–OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis

Por Ludwig, Michael D, Zagon, Ian S, McLaughlin, Patricia J
Publicado no Exp Biol Med (Maywood) (2018)

Naltrexone as a Novel Therapeutic for Diabetic Corneal Complications

Por McLaughlin, Patricia J., Sassani, Joseph W., Zagon, Ian S.
Publicado no J Cell Immunol (2020)

The OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancer

Por Cheng, Fan, McLaughlin, Patricia J, Verderame, Michael F, Zagon, Ian S
Publicado em 2008

The OGF–OGFr Axis Utilizes the p16(INK4a) and p21(WAF1/CIP1) Pathways to Restrict Normal Cell Proliferation

Por Cheng, Fan, McLaughlin, Patricia J., Verderame, Michael F., Zagon, Ian S.
Publicado em 2009

Naltrexone and Insulin Are Independently Effective but Not Additive in Accelerating Corneal Epithelial Healing in Type I Diabetic Rats

Por Klocek, Matthew S., Sassani, Joseph W., McLaughlin, Patricia J., Zagon, Ian S.
Publicado em 2009

Diabetic Keratopathy and Treatment by Modulation of the Opioid Growth Factor (OGF) - OGF Receptor (OGFr) Axis With Naltrexone: A Review

Por McLaughlin, Patricia J., Sassani, Joseph W., Klocek, Matthew S., Zagon, Ian S.
Publicado em 2009

Topical Naltrexone Reverses Dry Eye and Restores Corneal Sensation in Diabetes Mellitus

Por Zagon, Ian S., Klocek, Matthew S., Sassani, Joseph W., McLaughlin, Patricia J.
Publicado em 2009

Internalization of the opioid growth factor, [Met(5)]-enkephalin, is dependent on clathrin-mediated endocytosis for downregulation of cell proliferation

Por Cheng, Fan, McLaughlin, Patricia J., Banks, William A., Zagon, Ian S.
Publicado em 2010

Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of...

Por Hammer, Leslie A, Waldner, Hanspeter, Zagon, Ian S, McLaughlin, Patricia J
Publicado no Exp Biol Med (Maywood) (2015)

Dysregulation of the OGF–OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat

Por Zagon, Ian S, Sassani, Joseph W, Purushothaman, Indira, McLaughlin, Patricia J
Publicado no Exp Biol Med (Maywood) (2020)

Topical Application of Naltrexone Facilitates Reepithelialization of the Cornea in Diabetic Rabbits

Por Zagon, I. S., Sassani, Joseph W., Carroll, Melissa A., McLaughlin, Patricia J.
Publicado em 2009

Spontaneous Episodic Decreased Tear Secretion in Rats Is Related to Opioidergic Signaling Pathways

Por Zagon, Ian S., Campbell, Anna M., Sassani, Joseph W., McLaughlin, Patricia J.
Publicado em 2012

Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis

Por Ludwig, Michael D, Turel, Anthony P, Zagon, Ian S, McLaughlin, Patricia J
Publicado no Mult Scler J Exp Transl Clin (2016)

Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes

Por McLaughlin, Patricia J., Sassani, Joseph W., Titunick, Michelle B., Zagon, Ian S.
Publicado no BMC Ophthalmol (2019)